| Title | AN ACT relating to prescription insulin. |
|---|---|
| Bill Documents | Original |
| Sponsors | P. Wheeler |
| Summary of Original Version | Amend KRS 304.17A-148 to cap the cost-sharing requirements for prescription insulin at $100 per 30-day supply; create a new section of KRS Chapter 315 to require pharmaceutical manufacturers and wholesale distributors to rebate individuals for a portion of their out-of-pocket expenses paid for prescription insulin; EFFECTIVE January 1, 2021. |
| Index Headings |
Diseases - Diabetes, prescription insulin drug, cost sharing, capped Diseases - Diabetes, prescription insulin drugs, cost sharing, rebate established Drugs and Medicines - Prescription insulin drugs, cost sharing, capped Drugs and Medicines - Prescription insulin drugs, cost sharing, rebate established Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2021 Health and Medical Services - Prescription insulin drugs, cost sharing, capped Insurance, Health - Prescription insulin drugs, cost sharing, capped |
| 10/07/19 | Prefiled by the sponsor(s). |
|---|
Last updated: 12/18/2019 1:45 PM (EST)
To receive notice when the record is updated follow @LRCTweetBot. @LRCTweetBot